BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 29755114)

  • 1. 3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis.
    Mu M; Zhang Q; Zhao C; Li X; Chen Z; Sun X; Yu J
    Cancer Gene Ther; 2023 Oct; 30(10):1414-1425. PubMed ID: 37558749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer.
    Morimoto Y; Yamashita N; Hirose H; Fushimi A; Haratake N; Daimon T; Bhattacharya A; Ahmad R; Suzuki Y; Takahashi H; Kufe DW
    Cancer Lett; 2023 Apr; 559():216116. PubMed ID: 36878307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of the new tyrphostin briva against BRAF
    Saleh K; Al Sakhen M; Kanaan S; Yasin S; Höpfner M; Tahtamouni L; Biersack B
    Invest New Drugs; 2023 Dec; 41(6):791-801. PubMed ID: 37870738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KZ02 enhances the radiosensitivity of BRAF-mutated CRC in vitro and in vivo.
    Guo Y; Li X; Yuan R; Ren J; Huang Y; Yu Y; Tian H
    Eur J Pharmacol; 2023 Nov; 959():176060. PubMed ID: 37775019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of Cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo.
    Žilinskas J; Stukas D; Jasukaitienė A; Žievytė I; Balion Z; Šapauskienė J; Banienė R; Paužas H; Lizdenis P; Čėsna V; Dambrauskas Ž; Gulbinas A; Tamelis A
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256402
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAF.
    Whittaker S; Ménard D; Kirk R; Ogilvie L; Hedley D; Zambon A; Lopes F; Preece N; Manne H; Rana S; Lambros M; Reis-Filho JS; Marais R; Springer CJ
    Cancer Res; 2010 Oct; 70(20):8036-44. PubMed ID: 20807807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models.
    Maione F; Oddo D; Galvagno F; Falcomatà C; Pandini M; Macagno M; Pessei V; Barault L; Gigliotti C; Mira A; Corti G; Lamba S; Riganti C; Castella B; Massaia M; Rad R; Saur D; Bardelli A; Di Nicolantonio F
    Mol Oncol; 2024 Jun; 18(6):1552-1570. PubMed ID: 38348572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive Cytotoxic and Colony-Formation Inhibitory Effects of Aspirin and Metformin on
    Gonçalves J; Pinto S; Carmo F; Silva C; Andrade N; Martel F
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ERK inhibitor GDC-0994 selectively inhibits growth of BRAF mutant cancer cells.
    Chen Y; Sang Y; Li S; Xue J; Chen M; Hong S; Lv W; Sehgal K; Xiao H; Liu R
    Transl Oncol; 2024 Jul; 45():101991. PubMed ID: 38728872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced ALDH3A1 promotes the proliferation of non-small-cell lung cancer by regulating energy metabolism reprogramming.
    Chen Y; Yan H; Yan L; Wang X; Che X; Hou K; Yang Y; Li X; Li Y; Zhang Y; Hu X
    Cell Death Dis; 2023 Sep; 14(9):617. PubMed ID: 37730658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF.
    Feng K; Shi Q; Jiao D; Chen Y; Yang W; Su K; Wang Y; Huang Y; Zhang P; Li Y; Wang C
    Cell Biosci; 2022 Dec; 12(1):211. PubMed ID: 36585710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of BRAF/HDAC Dual Inhibitors Suppressing Proliferation of Human Colorectal Cancer Cells.
    Li Y; Huang Y; Cheng H; Xu F; Qi R; Dai B; Yang Y; Tu Z; Peng L; Zhang Z
    Front Chem; 2022; 10():910353. PubMed ID: 35936102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer.
    Ma R; Qu X; Che X; Yang B; Li C; Hou K; Guo T; Xiao J; Liu Y
    Onco Targets Ther; 2021; 14():3517-3534. PubMed ID: 34103942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28.
    Zhang C; Fan Y; Che X; Zhang M; Li Z; Li C; Wang S; Wen T; Hou K; Shao X; Liu Y; Qu X
    Front Oncol; 2020; 10():760. PubMed ID: 32528882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of the COX2/PGE
    Yoshitake R; Saeki K; Eto S; Shinada M; Nakano R; Sugiya H; Endo Y; Fujita N; Nishimura R; Nakagawa T
    Sci Rep; 2020 May; 10(1):7826. PubMed ID: 32385388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex.
    Fang W; Che X; Li G; Wang A; Wang Y; Shi X; Hou K; Zhang X; Qu X; Liu Y
    J Exp Clin Cancer Res; 2020 May; 39(1):82. PubMed ID: 32381104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status.
    Ma R; Xu L; Qu X; Che X; Zhang Y; Fan Y; Li C; Guo T; Hou K; Hu X; Drew L; Shen M; Cheung T; Liu Y
    Br J Cancer; 2018 May; 118(11):1453-1463. PubMed ID: 29755114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.
    Yang H; Higgins B; Kolinsky K; Packman K; Bradley WD; Lee RJ; Schostack K; Simcox ME; Kopetz S; Heimbrook D; Lestini B; Bollag G; Su F
    Cancer Res; 2012 Feb; 72(3):779-89. PubMed ID: 22180495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers.
    Tang Z; Yuan X; Du R; Cheung SH; Zhang G; Wei J; Zhao Y; Feng Y; Peng H; Zhang Y; Du Y; Hu X; Gong W; Liu Y; Gao Y; Liu Y; Hao R; Li S; Wang S; Ji J; Zhang L; Li S; Sutton D; Wei M; Zhou C; Wang L; Luo L
    Mol Cancer Ther; 2015 Oct; 14(10):2187-97. PubMed ID: 26208524
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.